Feedback / Questions
Rubraca (rucaparib) - Clovis
Rubraca: Data from monotherapy portion of P3 ATHENA trial (NCT03522246) for 1L ovarian cancer in H2 2021
(Clovis Oncology)
-
Jun 5, 2020 -
Corporate Presentation
P3 data
•
Oncology • Ovarian Cancer
https://s22.q4cdn.com/778348918/files/doc_presentations/2020/CLVS-presentation-FINAL-05-2020-for-website.pdf
Jun 5, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious